Hematological Malignancies
No WBRT
Highly criticized: • Poor protocol adherence • Non-inferiority goal in OS not met • Insufficient toxicity evaluation • Overall poor results, sub-optimal chemo
• Neurotoxicity even with chemo alone (26%), with RT (49%) • Salvage improved survival, but carries high QOL/toxicity cost
35
Made with FlippingBook